News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
169,793 Results
Type
Article (6860)
Company Profile (81)
Press Release (162852)
Multimedia
Podcasts (8)
Webinars (1)
Section
Business (56735)
Career Advice (180)
Deals (11551)
Drug Delivery (11)
Drug Development (20557)
Employer Resources (24)
FDA (3611)
Job Trends (3572)
News (89864)
Policy (6789)
Tag
2027 Genetown Elite (1)
2027 Genetown Standard (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (1)
Academia (621)
Accelerated approval (7)
Adcomms (1)
Allergies (45)
Alliances (8079)
ALS (35)
Alzheimer's disease (390)
Antibody-drug conjugate (ADC) (95)
Approvals (3741)
Artificial intelligence (70)
Autoimmune disease (34)
Automation (4)
Bankruptcy (57)
Best Places to Work (3182)
Biosimilars (38)
Biotechnology (63)
Bladder cancer (58)
Brain cancer (14)
Breast cancer (192)
Cancer (1390)
Cardiovascular disease (97)
Career advice (160)
Career pathing (4)
CAR-T (73)
CDC (6)
Cell therapy (162)
Cervical cancer (13)
Clinical research (18123)
Collaboration (248)
Compensation (204)
Complete response letters (8)
COVID-19 (947)
CRISPR (16)
C-suite (82)
Cystic fibrosis (26)
Data (1849)
Depression (31)
Diabetes (133)
Diagnostics (1738)
Digital health (7)
Diversity (1)
Diversity, equity & inclusion (6)
Drug discovery (37)
Drug pricing (27)
Drug shortages (1)
Duchenne muscular dystrophy (38)
Earnings (41698)
Editorial (10)
Employer branding (4)
Employer resources (22)
Events (26841)
Executive appointments (93)
FDA (4490)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (2)
Frontotemporal dementia (10)
Funding (248)
Gene editing (39)
Generative AI (4)
Gene therapy (112)
GLP-1 (288)
Government (1274)
Grass and pollen (3)
Guidances (312)
Healthcare (5391)
HIV (9)
Huntington's disease (10)
IgA nephropathy (16)
Immunology and inflammation (59)
Immuno-oncology (13)
Indications (26)
Infectious disease (1011)
Inflammatory bowel disease (43)
Inflation Reduction Act (2)
Influenza (25)
Intellectual property (40)
Interviews (27)
IPO (7933)
IRA (5)
Job creations (540)
Job search strategy (140)
JPM (7)
Kidney cancer (5)
Labor market (25)
Layoffs (130)
Leadership (5)
Legal (1073)
Liver cancer (18)
Longevity (1)
Lung cancer (217)
Lymphoma (164)
Machine learning (5)
Management (5)
Manufacturing (122)
MASH (54)
Medical device (3847)
Medtech (3860)
Mergers & acquisitions (3860)
Metabolic disorders (330)
Multiple sclerosis (52)
NASH (5)
Neurodegenerative disease (72)
Neuropsychiatric disorders (26)
Neuroscience (679)
NextGen: Class of 2026 (1308)
Non-profit (1071)
Now hiring (9)
Obesity (140)
Opinion (26)
Ovarian cancer (33)
Pain (27)
Pancreatic cancer (59)
Parkinson's disease (61)
Partnered (5)
Patents (63)
Patient recruitment (99)
Peanut (24)
People (8616)
Pharmaceutical (14)
Pharmacy benefit managers (4)
Phase 1 (4821)
Phase 2 (7798)
Phase 3 (7093)
Pipeline (2209)
Policy (31)
Postmarket research (608)
Preclinical (1692)
Press Release (12)
Prostate cancer (76)
Psychedelics (4)
Radiopharmaceuticals (137)
Rare diseases (172)
Real estate (867)
Recruiting (13)
Regulatory (5443)
Reports (17)
Research institute (477)
Resumes & cover letters (17)
Rett syndrome (12)
RNA editing (1)
RSV (26)
Schizophrenia (38)
Series A (30)
Series B (26)
Service/supplier (5)
Sickle cell disease (26)
Special edition (6)
Spinal muscular atrophy (49)
Sponsored (9)
Startups (546)
Stomach cancer (5)
Supply chain (13)
Tariffs (17)
The Weekly (7)
Vaccines (197)
Venture capital (14)
Weight loss (98)
Women's health (13)
Worklife (1)
Date
Today (4)
Last 7 days (137)
Last 30 days (435)
Last 365 days (7724)
2026 (655)
2025 (7905)
2024 (9256)
2023 (10008)
2022 (11970)
2021 (31695)
2020 (19917)
2019 (10088)
2018 (7140)
2017 (6708)
2016 (5810)
2015 (7095)
2014 (4816)
2013 (3602)
2012 (3802)
2011 (4407)
2010 (4362)
Location
Africa (124)
Alabama (11)
Alaska (2)
Arizona (44)
Arkansas (3)
Asia (10179)
Australia (1208)
California (2601)
Canada (937)
China (253)
Colorado (135)
Connecticut (112)
Delaware (120)
Europe (24433)
Florida (352)
Georgia (118)
Hawaii (1)
Idaho (13)
Illinois (275)
India (15)
Indiana (178)
Japan (133)
Kansas (22)
Kentucky (8)
Louisiana (8)
Maine (28)
Maryland (322)
Massachusetts (1899)
Michigan (97)
Minnesota (153)
Mississippi (1)
Missouri (20)
Montana (6)
Nebraska (1)
Nevada (27)
New Hampshire (19)
New Jersey (978)
New Mexico (2)
New York (689)
North Carolina (337)
Northern California (1361)
Ohio (67)
Oklahoma (1)
Oregon (12)
Pennsylvania (643)
Puerto Rico (3)
Rhode Island (6)
South America (207)
South Carolina (6)
Southern California (929)
Tennessee (53)
Texas (351)
United States (9798)
Utah (99)
Vermont (1)
Virginia (45)
Washington D.C. (11)
Washington State (230)
Wisconsin (30)
169,793 Results for "22".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Phio Pharmaceuticals Announces Participation in the Sidoti Micro-Cap Virtual Investor Conference January 21-22, 2026
Registration Link for Phio’s Presentation on Thursday, January 22 at 1:45 PM ET
January 15, 2026
·
5 min read
Press Releases
JCR Pharmaceuticals to Present at the 22nd Annual WORLDSymposium™ 2026
January 28, 2026
·
8 min read
Press Releases
Spruce Biosciences Announces Data Presentations at the 22nd Annual WORLDSymposium™
January 29, 2026
·
2 min read
Press Releases
Zevra Therapeutics to Present Multiple Analyses on MIPLYFFA® at the 22nd Annual WORLDSymposium™
January 27, 2026
·
4 min read
Press Releases
Polaryx Announces Key Pre-Clinical Data Related to SOTERIA at the 22nd Annual WORLDSymposium™
February 10, 2026
·
8 min read
Press Releases
Ocugen, Inc. Announces Pricing of $22.5 Million Offering of Common Stock
January 22, 2026
·
3 min read
Press Releases
Optimi Health to Present at the Sidoti Micro-Cap Conference on January 21-22, 2026
January 14, 2026
·
4 min read
Mergers & acquisitions
GSK Picks Up RAPT for $2.2B as Miels Makes First Move as CEO
The star of the acquisition, anti-IgE antibody ozureprubart, is being tested as a prophylactic treatment for food allergies, potentially setting up a competition for GSK with Roche’s Xolair.
January 20, 2026
·
2 min read
·
Tristan Manalac
Press Releases
Ocugen, Inc. Announces Closing of $22.5 Million Underwritten Registered Direct Offering of Common Stock
January 26, 2026
·
3 min read
Press Releases
Polaryx to Present Late-Breaker Data Related to SOTERIA at the 22nd Annual WORLDSymposium™ as Company Prepares for SOTERIA Trial Launch
February 3, 2026
·
7 min read
1 of 16,980
Next
